Sociology has tried, with mixed success, to define a realm of analysis that goes beyond the individual, and to grasp what is “in-between,” using names like “interaction,” “structures,” “communication,” or […]
Month: April 2017
Richard Smith: What have I achieved in six years of teaching?
Yesterday as I flew home from teaching in Amsterdam for the last time, I wondered what I might have achieved in six (or perhaps it’s seven) years of teaching. Twice […]
Richard Lehman’s journal review—24 April 2017
Richard Lehman reviews the latest research in the top medical journals […]
Jeffrey Aronson: When I use a word . . . Defining translational research
Over the past four weeks I have been exploring models of translational research using the metaphor of crossing bridges. I started by exploring the meanings of translation. It comes from […]
Combatting NTDs: Much progress, but millions of patients lack access to care
Julien Potet on the next steps we need to take in the fight against neglected tropical diseases […]
Emma Cave: Brexit and the regulation of clinical trials
As the UK negotiates its exit from the EU, Emma Cave considers the implications for the implementation of the new Clinical Trials Regulation, likely to come into operation in 2018. The […]
Simon Denegri: Is a better public debate about patient data on the horizon?
Few would argue that the public have been well served by the debate about how their data can support care and research now and in the future. After the shipwreck […]
Richard Smith: Tales of sustainability II—a way forward from Brighton
The NHS is legally committed to reducing its carbon consumption by 80% by 2050, but the route to that destination is far from clear. The leaders in trying to find […]
The language doctors and medical journals use to describe dependence has a real effect on patients
Journals have a responsibility to communicate clearly in ways that benefit patients […]
James Raftery: NICE’s proposed new QALY modifier for appraising highly specialised technologies
After a consultation on changes to its methods for appraising health technologies, the National Institute for Health and Care Excellence (NICE) has gone public with its way forward. As discussed previously, the consultation […]